Neudle.com: glutamate receptors

Neurology Specific Literature Search

Differential
(Click to cross reference)

acute disseminated encephalomyelitis

advances in neurology

adverse drug reaction

alveolar hypoventilation

Alzheimer's disease

Alzheimer's disease, treatment of

amnesia, anterograde

amnestic syndrome

AMPA receptor antibodies

amphiphysin antibodies

amyotrophic lateral sclerosis

amyotrophic lateral sclerosis, etiology of

amyotrophic lateral sclerosis, treatment of

anti GQ1b IgG antibody

anti Hu antibody

anti MAG antibodies

anti Ri antibody

anticholinesterase

arrhythmia, cardiac

ataxia, cerebellar

ataxia, progressive

ataxia, truncal

autoimmune basal ganglia encephalitis

autoimmune cerebellar ataxia

autoimmune disease

autoimmune encephalopathy

autoimmune epilepsy

automobile accidents

autonomic dysfunction

autonomic neuropathy

basal ganglia, lesion of

basal ganglia, lesion, bilateral

behavior, combative

behavioral disorder

behavioral disorder, acute

brainstem, lesion of

calcium antagonist

carcinoma of breast

carcinoma of lung

carcinoma of ovary

carcinoma of pancreas

CAT scan, chest

CAT scan, emission

CAT scan, emission, abnormal

CAT scan, pelvis

celiac disease, adult

central nervous system, infection of

cerebellar ataxia, primary

cerebellar atrophy, primary

cerebellar degeneration

cerebellar lesion

cerebellar peduncle

cerebellitis, autoimmune

cerebral cortex

cerebral embolism

cerebral ischemia

cerebrospinal fluid

cerebrospinal fluid, abnormal

cerebrospinal fluid, elevated protein of

cerebrospinal fluid, gammaglobulin of

cerebrospinal fluid, oligoclonal IgG in

cerebrovascular accident

cerebrovascular accident, acute management of

cerebrovascular accident, pathophysiology

cerebrovascular accident, prevention of

cerebrovascular accident, thrombolytic agents in treatment

cerebrovascular accident, time of presentation

choreoathetosis

Clinical Pathologic Conference(C.P.C.)

collapsin response mediator protein 5 IgG

coma, medically induced

common variable immunodeficiency

conjugate gaze, forced

contactin associated protein like 2 antibodies

contractures, joint

controversies in neurology

conversion reaction

creatine phosphokinase(CPK)elevated

cyclophosphamide

cytochrome c oxidase

deep gray nuclei

degenerative diseases of CNS

dementia, reversible

dementia, treatment of

demyelinating disease

dermatomyositis

developmental milestones, loss of

diabetes mellitus

diagnostic criteria

differential diagnosis

disability, neurological

down-beat nystagmus

DPPX, antibodies

DPPX, antibodies, encephalitis

dura, thickened

dyskinesia, buccal lingual facial

dyskinesia, facial

electroencephalogram

electroencephalogram, abnormalities of

emotional lability

encephalitis lethargica

encephalitis, autoimmune

encephalitis, brainstem

encephalitis, clinical picture and treatment of

encephalitis, etiology

encephalitis, paraneoplastic

encephalitis, unilateral

encephalitis, unknown etiology

encephalitis, viral

encephalitis, viral-causes of

encephalomyelitis

encephalomyelitis, autoimmune

encephalomyelitis, paraneoplastic

encephalopathy, Hashimoto's

encephalopathy, progressive

epidemiology of neurology

extralimbic encephalitis

extreme delta brush

eye movement, disorders of

face, numbness of

faciobrachial dystonic seizure

fibrinolytic agents

Fisher's syndrome

flu-like illness

gamma amino butyric acid

gamma amino butyric acid receptor antibody

gammaglobulin therapy, intravenous

gaze palsy, horizontal

glutamic acid decarboxylase, antibody

glycine receptor antibodies

Guillain Barre syndrome, variant forms of

gyrus, abnormal

hallucination, visual

heralding manifestation

herpes simplex encephalitis

herpes simplex encephalitis, atypical

herpes simplex encephalitis, recurrent

herpes simplex virus

hippocampal atrophy

hippocampus, hyperintense

Hodgkin's disease

Hodgkin's disease, neurologic involvement with

hyperthyroidism

hypoxic encephalopathy

immune checkpoint inhibitors

immune-related adverse events

immunologic disease

immunology and the nervous system

immunomodulation

immunosuppression

immunosuppressive agents

inappropriate antidiuretic(A.D.H.)hormone

inborn errors of metabolism, screening

intellectual deficit

intellectual deterioration

internuclear ophthalmoplegia

internuclear ophthalmoplegia, bilateral

ischemic penumbra

Jakob-Creutzfeldt disease

laughing, pathologic

leg spasms, painful

leg weakness, bilateral

leucine rich glioma inactivated 1 antibodies

level of consciousness

level of consciousness, decreased

life expectancy

limbic encephalitis

lymphoma involving CNS

malignancy screen

malignancy, occult

mediastinum, mass of

memory, defect of recent

memory, impairment of

meningeal enhancement

mental status, abnormal

mesial temporal lobe

mesial temporal sclerosis

mGlu R5 antibodies

migraine, children

migraine, pathogenesis

monoclonal antibodies

Morvan's fibrillary chorea

motor neuron disease

movement disorder

movement disorder, extrapyramidal

movement disorder, psychogenic

MRI, contrast enhanced

MRI, diffusion weighted

MRI, disappearing lesion on

MRI, false negative

MRI, spinal cord

multiple sclerosis

muscle stiffness

myasthenia gravis, paraneoplastic

myasthenic syndrome

myelitis, autoimmune

myelitis, longitudinal

myelitis, transverse, recurrent

myoclonus, segmental

nausea and vomiting

neurexin-3 alpha antibodies

neuroendocrinology

neurologic complications

neurologic complications of, systemic cancer

neurologic disease

neurologic disease, diagnoses of

neurologic disease, multifocal

neurologic disease, multiple

neurologic examination, focal

neurologic signs

neuromuscular disease, electrodiagnosis of

neuromuscular junction

neuromyelitis optica (Devic's disease)

neuromyelitis optica, IgG

neuronal cell surface antigen

neuronopathy, sensory

neuroophthalmology

neuropathology, brain

neuropathy, paraneoplastic

neuroprotective agents

neurotransmitter

NMDA antagonist, late onset

NMDA antagonists

noncommunicative

novel cell-membrane antigens

nystagmus, upbeating on upgaze

nystagmus, vertical

old age, neurology of

olivary degeneration, hypertrophic

onconeural antibodies

ophelia syndrome

ophthalmoplegia

opsoclonus-myoclonus syndrome

overlap syndrome

pachymeningitis, cranial

palatal myoclonus

paraneoplastic brainstem encephalitis

paraneoplastic cerebellar degeneration

paraspinal muscle

Parkinson disease

Parkinson disease, treatment of

Parkinsonism syndrome

Parkinsonism, freezing phenomena in

paroxysmal neurologic disorder

pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection

peripheral nerve, lesion of

personality change

pleocytosis of cerebrospinal fluid

pons, lesion of

post herpes simplex encephalitis immune-mediated relapse

postural abnormality

potassium channel antibodies

practice guidelines

precipitating factors

prevention of neurologic disorders

progressive encephalomyelitis with rigidity syndrome

progressive neurologic disorder

psychiatric problems in neurologic disorders

psychosis, acute

psychosis, childhood

psychotic behavior

pupil, abnormality in neurologic disorders

Purkinje cell surface antibody

pyramidal tract

rabies, nervous system involvement with

release phenomena

remote effect of cancer on the nervous system

reversal of sleep wake cycle

reversible neurologic disorder

salivation, excessive

Schmidt syndrome

seizure, adult onset

seizure, drug resistance

seizure, intractable

seizure, intractable, treatment of

seizure, medication failure

seizure, psychomotor-temporal lobe

seizure, treatment of

seizure, unknown origin

serologic testing

serologic testing of cerebrospinal fluid

serologic testing, false negative

sexual behavior, disorder of

sleep pathology and physiology

speech disorder

speech disorder, childhood

spinal cord, cervical

spinal cord, lesion of

standing difficulty

startle reaction

status epilepticus

status epilepticus, nonconvulsive

steroid responsive encephalopathy

steroid therapy, CNS treatment and complications with

stiff limb syndrome

stiff man syndrome

stiff man syndrome, variant

stress, emotional

striatal encephalitis

striatum, lesion of

striatum, lesion of, bilateral

stroke, progression of

superior cerebellar peduncle

sweating, abnormality of

symmetric brain lesions

syphilis, neurologic complications with

temporal lobe, lesion

temporal lobe, lesion, bilateral

teratoma, ovarian

testicular teratoma

thrombocytopenia

thyroid function tests

tissue plasminogen activator, intravenous

tone, muscle, increased

tongue, protrusion of

transient ischemic attack

treatment of neurologic disorder

triangle of Guillain and Mollaret

unconsciousness

urinary retention

varicella zoster virus

violent behavior

viral infection

viral infection, CNS

vision, blurred

walking, difficulty with

white matter disease

white matter disease, subcortical

wide based gait

Showing articles 600 to 650 of 787 << Previous Next >>

Diagnosis and Management of Hormone-Secreting Pituitary Adenomas
NEJM 324:822-831, Klibanski,A.&Zervas,N.T., 1991

Central Nervous System Reactions to Histamine-2 Receptor Blockers
Ann Int Med 114:1027-1034, Cantu,T.G.&Korck,J.S., 1991

Oral Sumatriptan in Acute Migraine
Lancet 338:782-783, Goadsby,P.J.,et al, 1991

Magnetic Resonance Imaging of Limbic Encephalitis
Neuroradiology 33:520-523, Kodama,T.,et al, 1991

A Multi-Center, Double-Blind Study on Slow-Release Bromocriptine in the Treatment of Parkinson's Disease
Neurol 41:1598-1602, Mannen,T.,et al, 1991

Pleuropulmonary Disease Associated with Dopamine Agonist Therapy
Ann Neurol 30:613-616, Bhatt,M.H.,et al, 1991

The Apomorphine Test in Parkinsonian Syndromes
JNNP 54:870-872, D'Costa,D.F.,et al, 1991

Paraneoplastic Limbic Encephalitis:Clinicopathological Correlations
JNNP 53:1084-1088, Bakheit,A.M.O.,et al, 1990

Treatment of Prolactin-Secreting Pituitary Macroadenomas with the Long-Acting Non-Ergot Dopamine Agonist CV 205-502
Ann Int Med 112:668-673, Vance,M.L.,et al, 1990

Acromegaly
NEJM 322:966-977, Melmed,S., 1990

Evolution of Brain MRI Abnormalities in Limbic Encephalitis
Neurol 40:1304-1306, Dirr,L.Y.,et al, 1990

Anatomy, Physiology, and Pathology of Epilepsy
lancet 336:231-232, Meldrum,B.S., 1990

Diagnostic Utility of Flumazenil in Coma with Suspected Poisoning:A Double Blind, Randomized Controlled Study
BMJ 301:1308-1311, Hojer,J.,et al, 1990

Limbic Encephalitis Associated with Thymoma
Neurol 40:383, Ingenito,G.G.,et al, 1990

MR Imaging of Paraneoplastic Limbic Encephalitis
J Comput Assist Tomogr 14:115-117, Lacomis,D.,et al, 1990

Bromocriptine-Induced Hypothermia
Neurol 40:383, Pfeiffer,R.F., 1990

Subcutaneous Apomorphine in the Treatment of Parkinson's Disease
JNNP 53:96-101, Frankel,J.P.,et al, 1990

Nasogastric and Intravenous Infusions of (+) -4-propyl-9-hydroxynaphthoxazine (PHNO) in Parkinson's Disease
JNNP 53:102-105, 1990, Coleman,R.J.,et al, 1990

Abnormalities of Striatal Projection Neurons and n-Methyl-d-Aspartate Receptors in Presymptomatic Huntington's Disease
NEJM 322:1293-1298, Albin,R.L.,et al, 1990

Oculogyric Crisis after Metoclopramide Therapy
Optometry and Vision Science 66:179-180, Edward,M.,et al, 1989

Bromocriptine in Parkinson's Disease:A Double-Blind Study Comparing"Low-Slow"and"High-Fast"in de Novo Patients
UK Bromocriptine Res Group, JNNP 52:77-821989., , 1989

Lisuride, A Dopamine Agonist in the Treatment of Early Parkinson's Disease
Neurol 39:336-339, Rinne,U.K., 1989

Pergolide and Selegiline for Parkinson's Disease
The Medical Letter, 31:81-841989., , 1989

Agonist Substitution in Advanced Parkinson's Disease
Neurol 39:1121-1122, Goetz,C.G.,et al, 1989

Physiology & Pharmacology of Dopamine D2-Receptors:Their Implications in Dopamine-Substitute Therapy for Park
Neurol 39:1106-1108, Mercuri,N.B.,et al, 1989

Postmortem Analysis of Adrenal-Medulla-to-Caudate Autograft in a Patient with Parkinson's Disease
Ann Neurol 25:607-614, Hurtig,H.,et al, 1989

The Efficacy of (+) -4-Propyl-9-Hydroxynaphthoxazine as Adjunctive Therapy in Parkinson's Disease
JNNP 52:732-735, Weiner,W.J.,et al, 1989

Neuroleptic Malignant Syndrome, Review of Response to Therapy
Arch Int Med 149:1927-1931, Rosenberg,M.R.&Green,M., 1989

Metoclopramide-Induced Movement Disorders
Arch Int Med 149:2486-2492, Miller,L.G.&Jankovic,J., 1989

Drugs Acting on 5-Hydroxytryptamine Receptors
Editorial, Lancet 2:717-7191989., , 1989

The Remote Effects of Cancer on the Nervous System
in Neurol Manif of Systemic Dis, W. B. Saunders, Co, Phila, Neurologic Clinics 7:579-603, Dropcho,E.J., 1989

PHNO[ (+) -4-Propyl-9-Hydroxynaphthoxazine]:A New and Effective Anti-Parkinson's Disease Agent
Neurol 38:1541-1545, Muenter,M.D.,et al, 1988

Role of Subcutaneous Apomorphine in Parkinsonian Voiding Dysfunction
Lancet 2:1451-1453, Christmas,T.J.,et al, 1988

Neonatal Myasthenia Gravis:A New Clinical & Immunologic Appraisal on 30 Cases
Neurol 38:138-142, Morel,E.,et al, 1988

International Symposium on Early Dopamine Agonist Therapy of Parkinson's Disease
Arch Neurol 45:204-208, Kurlan,R., 1988

Seronegative Myasthenia Gravis
Neurol 38:514-517, Soliven,B.C.,et al, 1988

Maternal-Fetal Transmission of Myasthenia Gravis with Acetylcholine-Receptor Antibody
NEJM 318:996, Melber,D., 1988

Amelioration of Vincristine Neurotoxicity by Glutamic Acid
Am J Med 84:1016-1022, Jackson,D.V.,et al, 1988

Acute Upper Airway Obstruction Due to Supraglottic Dystonia Induced by a Neuroleptic
BMJ 297:964-965, Newton-John,H., 1988

Improvement of Hepatic Encephalopathy Treated with Flumazenil
Lancet 2:1392-1394, Grimm,G.,et al, 1988

Hyperprolactinaemia, Common and Treatable
BMJ 297:701-702, Hartog,M.&Hull,M.G.R., 1988

Clinicopath Conf
Paraneoplastic Encephalitis (Limbic and Brain-Stem Encephalitis) , Case Record 39-1988, NEJM 319:849, 860,, 1988

Dopamine Agonists, In Parkinson's Disease and Movement Disorders
Urban & Schwarzenberg, Balt, p. 104., Jankovic,J.&Tolosa,E., 1988

Possible Benefit of GR43175, A Novel 5-HT1-Like Receptor Agonist for the Acute Treatment of Severe Migraine
Lancet 1:1309-1311, Doenicke,A.,et al, 1988

Subcutaneous Apomorphine in Parkinsonian On-Off Oscillations
Lancet 1:403-406, Stibe,C.M.H.,et al, 1988

Pharmacotherapy for Aphasia
Neurol 38:877-879, Albert,M.L.,et al, 1988

A Double-Blind Randomized Crossover Trial of Bromocriptine & Placebo in Restless Legs Syndrome
Ann Neurol 24:455-458, Walters,A.S.,et al, 1988

Treatment of Gilles de la Tourette's Syndrome:Experience in a Predominantly Adult Population
Neurol 37:1828-1833, Mesulam,M.M.&Peterson,R.C., 1987

Giant Invasive Prolactinomas
Am J Med 83:995-1002, Murphy,F.Y.,et al, 1987

Early Combination of Bromocriptine & Levodopa in the Treatment of Parkinson's Disease:A 5-Year Follow-up
Neurol 37:826-828, Rinne,U.K., 1987

Showing articles 600 to 650 of 787 << Previous Next >>